Working together to reduce the global burden of kidney cancer

Kidney cancer is a global issue. Every year, 338,000 people worldwide will be diagnosed with kidney cancer.

Click here for shareable information, graphics and materials about kidney cancer for patient organisations worldwide.

2019 World Kidney Cancer Day

On 20 June 2019, patients, friends, carers, health professionals, researchers and local kidney cancer organisations around the world celebrated the third World Kidney Cancer Day. The 2019 theme, ‘We need to talk’, highlighted the urgent need for more awareness and action on kidney cancer around the globe.

ASCO 2019: Kidney Cancer Highlights

The American Society of Clinical Oncology Symposium (ASCO) annual conference was held in Chicago, USA May 31-June 4 2019, and was attended by over 40,000 cancer researchers, clinicians, patient advocates and others.
In this report we will highlight some of the presentations which were of particular interest with respect to the kidney cancer community.

Updates from IKCC

In reply toDebra Gottsleben

21 hours ago
@gottsled @kcCURE This research suggests barriers for physicians and hospital institutions to use social media for trial recruitment. We see an excellent role for patient organisations and medical associations #clinicaltrials #CancerResearch

View on Twitter

0

1

IKCC Kidney Cancer @IKCCorg

1 day ago
A few Complete Responses to celebrate in this (very mixed) rare variant #kidneycancer patient population. Further trials and #RWE needed to guide treatment for #rarecancers https://t.co/qS2nq74s0v

View on Twitter

Pavlos Msaouel, MD, PhD @PavlosMsaouel
In this new study published at @OncJournal and led by @JadChahoud we retrospectively analyzed the efficacy of nivolumab in 40 patients with metastatic non-clear cell #renalcellcarcinoma and compared with prior data. https://t.co/GFhXGkiZk1 #kidneycancer @KidneyCancer #rarecancers https://t.co/KI0JYW7SqD

3

10

IKCC Kidney Cancer Retweeted · Michael Staehler @MichaelStaehler

2 days ago
EMA CHMP recommends Avelumab + Axitinib for first line therapy in #kidneycancer in Europe . Another exciting option for patients !!⁦ @Uroweb⁩ ⁦ @IKCCorg⁩ ⁦ @kcCURE⁩ https://t.co/JrfQGvsLLd

View on Twitter

15

0

Did you know?

Kidney cancer is often found by accident.

Kidney cancer is the 12th most prevalent cancer worldwide.

About 59 per cent of kidney cancer cases occur in more developed countries.

Our Global Network

IKCC welcomes every organisation that has an interest in kidney cancer and who pledges to conform to our Code of Conduct. We extend an open invitation to become part of this international network.

Explore Our Global Network